How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MD

NASDAQ:MDXG
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MD

MiMedx Group IncNASDAQ MDXG Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is MDXG undervalued compared to its fair value?

The fair value of MDXG stock is hidden USD. Relative to the market price of 7.42 USD MiMedx Group Inc is hidden.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. The company is headquartered in Marietta, Georgia and currently ...[More about valuation]

MiMedx Group Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

1.104 $B

Price:

7.42 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.062

FINANCIALS

MiMedx Group financial for reporting period

Income Statement

0.085 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.014 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0093 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.085 B 100%
0.072 B 85%
0.0093 B 11%

Balance Sheet

0.22 B
0.16 B

0.019 B

Financial Position Analysis

Assets

0.22 B
Current Assets
0.14 B
Total non-current assets
0.083 B

Total current liabilities
0.042 B
Total non-current liabilities
0.024 B

Cash Flow Statement

-0.026 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.006 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

MiMedx Group fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

53 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
83 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
30 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is MDXG attractive for investment based on fundamental analysis?

MDXG stock rating is hidden. MiMedx Group is a hidden by Eyestock methodology.

Get MDXG Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

19

Gross Margin:

83

CFO / Debt ratio:

hidden

Current ratio:

3.396

Debt / Equity ratio:

0.352

ROE:

53

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

MDXG analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for MDXG to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

MiMedx Group Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

MiMedx Group Inc dividends

MDXG dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About MDXG stock

About the company MiMedx Group Inc

Market cap $B

1.104

Dividend yield

Shares outstanding

114.083 B

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. The company is headquartered in Marietta, Georgia and currently employs 867 full-time employees. The company went IPO on 2007-08-20. The firm is focused on addressing unmet clinical needs in the areas of advanced wound care, surgical recovery applications, and musculoskeletal conditions. The Company’s primary platform technologies include EPIFIX, AMNIOFIX, EPICORD, and AMNIOCORD. The AMNIOFIX and EPIFIX are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. Its EPICORD and AMNIOCORD are tissue allografts derived from umbilical cord tissue. EPIFIX is a semi-permeable, protective barrier allograft comprised of dehydrated human amnion/chorion membrane that may be used in the treatment of chronic wounds, including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers. AMNIOFIX is used in surgical recovery applications including in the areas of spine, orthopedic, sports medicine and urologic.

MDXG profile

  • Ticker

    MDXG

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    20 August 2007

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    867

  • City

    Marietta

  • Address

    1775 W Oak Commons Court, Ne

  • Cusip

    602496101